Download MendeleyHigh-resolution crystal structures of the D1 and D2 domains of protein tyrosine phosphatase epsilon for structure-based drug design.
Lountos, G.T., Raran-Kurussi, S., Zhao, B.M., Dyas, B.K., Burke Jr., T.R., Ulrich, R.G., Waugh, D.S.(2018) Acta Crystallogr D Struct Biol 74: 1015-1026
- PubMed: 30289412
- DOI: https://doi.org/10.1107/S2059798318011919
- Primary Citation of Related Structures:
6D3F, 6D4D, 6D4F - PubMed Abstract:
Here, new crystal structures are presented of the isolated membrane-proximal D1 and distal D2 domains of protein tyrosine phosphatase epsilon (PTPℇ), a protein tyrosine phosphatase that has been shown to play a positive role in the survival of human breast cancer cells. A triple mutant of the PTPℇ D2 domain (A455N/V457Y/E597D) was also constructed to reconstitute the residues of the PTPℇ D1 catalytic domain that are important for phosphatase activity, resulting in only a slight increase in the phosphatase activity compared with the native D2 protein. The structures reported here are of sufficient resolution for structure-based drug design, and a microarray-based assay for high-throughput screening to identify small-molecule inhibitors of the PTPℇ D1 domain is also described.
Organizational Affiliation:
Basic Science Program, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Frederick, MD 21702, USA.
